News
Economics estimates the effective average tariff on US imports was reduced only marginally to 26.25% as a result of Wednesday ...
Despite U.S. President Donald Trump's decision this week to delay tariffs on major trading partners, experts remain ...
Wall Street economists maintained their forecasts for a sharp slowdown in U.S. economic growth and warned recession risk is still elevated despite the Trump administration’s decision this week to dela ...
Analysts have set 12-month price targets for Edwards Lifesciences, revealing an average target of $76.89, a high estimate of ...
Wall Street posted solid gains on Friday (April 11) as big banks kicked off first-quarter earnings season and investors ...
Morgan Stanley's long-time relationship with Tesla CEO Elon Musk paid off in the first quarter.
The gloomy forecasts stayed up even as stock markets rallied on the 90-day pause declared for tariffs excluding China.
Explore Morgan Stanley's record-breaking Q1 2025 earnings, highlighting $17.7B in revenue, equities strength, growing AUM, and robust M&A pipelines.
The stock, like those of its big bank peers, has been volatile in recent sessions as President Donald Trump's tariffs have created unprecedented U.S. market turmoil. The stock has fallen 16% in 2025, ...
Morgan Stanley posted better-than-expected first-quarter results on the back of record stock-trading revenue amid volatile ...
In a report released today, Vincent Andrews from Morgan Stanley maintained a Hold rating on Nutrien (NTR – Research Report), with a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results